Sage Journals: Discover world-class research

Open access

Research article

First published 2019-5

Association of body mass and systemic immune-inflammation indices with endocrine therapy resistance in luminal breast cancers

Qing-xia Li, Dong-jian Shi, Li-xia Zhang [...]

Journal of International Medical Research

Retricted access

Research article

First published 2012-7

Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer

James W Antoon, Martin D White, Jennifer L Driver [...]

Experimental Biology and Medicine

Retricted access

Research article

First published 2019-9

Time to treatment failure of palbociclib and letrozole as second-line therapy or beyond in hormone receptor-positive advanced breast cancer

M Alexandra Schickli, Michael J Berger, Maryam Lustberg [...]

Journal of Oncology Pharmacy Practice

Free access

Review article

First published 2016-11

Resistance to therapy in estrogen receptor positive and human epidermal growth factor 2 positive breast cancers: progress with latest therapeutic strategies

Laurence Lousberg, Joëlle Collignon, Guy Jerusalem

Therapeutic Advances in Medical Oncology

Free access

Research article

First published 2021-11-05

Relationship between endocrine resistance and the periods of adjuvant endocrine treatment for hormone receptor-positive,HER2-negative breast cancer

Jun Yamamura, Yukiko Miyamura, Shunji Kamigaki [...]

Breast Disease

Retricted access

Research article

First published 2024-4

Epigenetic Therapy Targets Endocrine-Resistant Breast Cancer

Genetic Engineering & Biotechnology News

Open access

Review article

First published 2021

Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer

Huimin Lv, Min Yan, Zefei Jiang

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2022

Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer

Song Xia, Qiong Lin

Technology in Cancer Research & Treatment

Open access

Review article

First published 2022

Clinical validity and clinical utility of Ki67 in early breast cancer

Hans Kreipe, Nadia Harbeck, Matthias Christgen

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2026

CDK4/6 inhibitors in invasive lobular carcinoma: Efficacy,resistance patterns,and endocrine partners

Saim Mahmood Khan, Aroobah Jawwad, Maheen Kashif [...]

Journal of Oncology Pharmacy Practice

Search results